Naoki Sakurai, Ph.D. has served as President and CEO (June, 2011 – March 2020) and COO (April 2020 – present) of Tanabe Research Laboratories. He has held numerous pharmaceutical roles, with increasing responsibilities, since joining Tanabe Seiyaku in 1985. He previously served as Director of the Research Division of Mitsubishi Tanabe Pharma, where he was responsible for biologics, biomarkers, target discovery, in-licensing and open-innovation alliance with academia. Before that, he was Director of Biology, leading multifunctional teams focused on inflammatory and metabolic diseases, and he served as the Senior Research Scientist of the Discovery Research Laboratory at Tanabe Seiyaku from 1998 to 2002, directing bone biology research and HTS/exploratory units to support various cross-functional projects. He also worked with Signal Pharmaceuticals (now Celgene) as a research scientist. Dr. Sakurai received his B.S., M.S., and Ph.D. from Kyoto University.